Qazi M Rizwanul Haque Selected Research

Neoplasms (Cancer)

10/2022	Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications.
1/2021	Targeting cyclin-dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qazi M Rizwanul Haque Research Topics

Disease

2	Neoplasms (Cancer) 10/2022 - 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

1	abemaciclibIBA 10/2022
1	palbociclibIBA 10/2022
1	ribociclibIBA 10/2022
1	vanillinIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Cyclin-Dependent Kinase 6IBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021

Therapy/Procedure

1	Therapeutics 10/2022